Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Tarextumab> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Tarextumab abstract "Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In Jan 2015 the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results.".
- Tarextumab wikiPageID "45307162".
- Tarextumab wikiPageLength "2171".
- Tarextumab wikiPageOutDegree "12".
- Tarextumab wikiPageRevisionID "679424971".
- Tarextumab wikiPageWikiLink Category:Experimental_cancer_drugs.
- Tarextumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Tarextumab wikiPageWikiLink Food_and_Drug_Administration.
- Tarextumab wikiPageWikiLink Lung_cancer.
- Tarextumab wikiPageWikiLink Monoclonal_antibody.
- Tarextumab wikiPageWikiLink Notch_2.
- Tarextumab wikiPageWikiLink Notch_3.
- Tarextumab wikiPageWikiLink Notch_signaling_pathway.
- Tarextumab wikiPageWikiLink Orphan_drug.
- Tarextumab wikiPageWikiLink Pancreatic_cancer.
- Tarextumab wikiPageWikiLinkText "Tarextumab".
- Tarextumab chemspiderid "NA".
- Tarextumab drugName "Tarextumab".
- Tarextumab hasPhotoCollection Tarextumab.
- Tarextumab legalStatus "Investigational".
- Tarextumab source "Human".
- Tarextumab target Notch_2.
- Tarextumab target Notch_3.
- Tarextumab type "mab".
- Tarextumab wikiPageUsesTemplate Template:Infobox_drug.
- Tarextumab wikiPageUsesTemplate Template:Pharma-stub.
- Tarextumab wikiPageUsesTemplate Template:Reflist.
- Tarextumab subject Category:Experimental_cancer_drugs.
- Tarextumab subject Category:Monoclonal_antibodies.
- Tarextumab type ChemicalSubstance.
- Tarextumab type Drug.
- Tarextumab type ChemicalObject.
- Tarextumab type Thing.
- Tarextumab type Q8386.
- Tarextumab comment "Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In Jan 2015 the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results.".
- Tarextumab label "Tarextumab".
- Tarextumab sameAs m.012sp0q7.
- Tarextumab wasDerivedFrom Tarextumab?oldid=679424971.
- Tarextumab isPrimaryTopicOf Tarextumab.